A national survey reveals that most individuals with hidradenitis suppurativa are unaware of US Food and Drug ...

Hidradenitis suppurativa (HS) highlights from AAD 2025 include studies of HS patients' risk for cardiovascular disease or ...

Learn about the common myths and misconceptions about hidradenitis suppurativa (HS) and why it is often misdiagnosed.

He is an Assistant Professor of Dermatology at the University of New Mexico and a fellow of the American Academy of ...

Topline data were announced from pivotal phase 3 studies evaluating povorcitinib in adults with moderate to severe hidradenitis suppurativa.

Study authors examined the relationship between the use of combined oral contraceptives and the onset of hidradenitis suppurativa.

Certain soaps and other skin care products may irritate hidradenitis suppurativa (HS), whereas others can help manage the condition and its symptoms. HS is a chronic skin condition that causes ...

A new drug application for povorcitinib is expected to be filed in late 2025 to early 2026 to treat adult patients with ...

Patients with hidradenitis suppurativa are at increased risk of developing several common inflammatory arthropathies in the years following diagnosis.

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin conditions like psoriasis, acne, and hidradenitis suppurativa by modulating key ...

One key opportunity for growth of the hidradenitis Suppurativa market is the untapped potential found in emerging countries with growing healthcare infrastructure and treatment availability. This ...